These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

905 related items for PubMed ID: 3136636

  • 1. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 2. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH, Kunze KP, Schlüter M, Duckeck W.
    Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 4. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
    Myerburg RJ, Kessler KM, Cox MM, Huikuri H, Terracall E, Interian A, Fernandez P, Castellanos A.
    Circulation; 1989 Dec 25; 80(6):1571-9. PubMed ID: 2480856
    [Abstract] [Full Text] [Related]

  • 5. Suppression of incessant supraventricular tachycardia by intravenous and oral encainide.
    Brugada P, Abdollah H, Wellens HJ.
    J Am Coll Cardiol; 1984 Dec 25; 4(6):1255-60. PubMed ID: 6438205
    [Abstract] [Full Text] [Related]

  • 6. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
    Fish FA, Gillette PC, Benson DW.
    J Am Coll Cardiol; 1991 Aug 25; 18(2):356-65. PubMed ID: 1906902
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardia.
    Bleske BE, Kluger J, Fisher J, Chow MS.
    J Clin Pharmacol; 1989 Nov 25; 29(11):998-1002. PubMed ID: 2513339
    [Abstract] [Full Text] [Related]

  • 8. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 9. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
    Niazi I, Naccarelli G, Dougherty A, Rinkenberger R, Tchou P, Akhtar M.
    J Am Coll Cardiol; 1989 Mar 15; 13(4):904-10. PubMed ID: 2494243
    [Abstract] [Full Text] [Related]

  • 10. Encainide for resistant supraventricular tachycardia in children: follow-up report.
    Strasburger JF, Smith RT, Moak JP, Gothing C, Garson A.
    Am J Cardiol; 1988 Dec 20; 62(19):50L-54L. PubMed ID: 3144168
    [Abstract] [Full Text] [Related]

  • 11. Effect of encainide and flecainide on chronic ectopic atrial tachycardia.
    Kunze KP, Kuck KH, Schlüter M, Bleifeld W.
    J Am Coll Cardiol; 1986 May 20; 7(5):1121-6. PubMed ID: 3082957
    [Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM, Lee JT, Woosley RL, Echt DS.
    Circulation; 1989 Nov 20; 80(5):1247-58. PubMed ID: 2805262
    [Abstract] [Full Text] [Related]

  • 13. Encainide and flecainide: are they interchangeable?
    Saini V, Podrid PJ, Slater W, Lown B.
    Am Heart J; 1989 Jun 20; 117(6):1253-8. PubMed ID: 2499169
    [Abstract] [Full Text] [Related]

  • 14. Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction. The Encainide-Ventricular Tachycardia Study Group.
    Am J Cardiol; 1988 Sep 15; 62(9):571-5. PubMed ID: 3137797
    [Abstract] [Full Text] [Related]

  • 15. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 16. Flecainide and encainide.
    Furlanello F, Vergara G, Bettini R, Mosna G, Gramegna L, Disertori M.
    Eur Heart J; 1987 Mar 25; 8 Suppl A():33-40. PubMed ID: 3107989
    [Abstract] [Full Text] [Related]

  • 17. Response to encainide of refractory ventricular tachycardia: clinical application of assays for parent drug and metabolites.
    Anderson JL, Stewart JR, Johnson TA, Lutz JR, Pitt B.
    J Cardiovasc Pharmacol; 1982 Mar 25; 4(5):812-9. PubMed ID: 6182414
    [Abstract] [Full Text] [Related]

  • 18. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV, Estes M, Heine DL, Griffith LS, Garan H, Ruskin JN, Reid PR.
    Am J Cardiol; 1985 Apr 01; 55(8):956-62. PubMed ID: 3984883
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
    Weintraub AR, Manolis AS, Estes NA.
    Am J Cardiol; 1990 Oct 15; 66(12):947-53. PubMed ID: 2121017
    [Abstract] [Full Text] [Related]

  • 20. Long-term antitachycardia pacing experience for supraventricular tachycardia.
    den Dulk K, Brugada P, Smeets JL, Wellens HJ.
    Pacing Clin Electrophysiol; 1990 Aug 15; 13(8):1020-30. PubMed ID: 1697949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.